journal cover

CSF α-synuclein, tau, and amyloid β in Parkinson's disease

Lancet Neurology

Jul 23, 2011

Min Shi, Jing Zhang

Abstract

No abstract listed.

Mentioned in this Paper

MAPT protein, human
Peptide Fragments
Tau Proteins
Parkinson Disease
Alpha-Synuclein
Viral Markers
Amyloid beta-Peptides
Amyloid beta-protein (1-42)
1
18
Paper Details
References

Similar Papers Found In These Feeds

Galectins & Alpha-Synuclein

Galectins proteins bind to sugar molecules and mediate the cellular response to endocytic vesicles. It is believed that some galectin proteins are involved in microglia activation induced by α-synuclein. Here is the latest research on galectins and alpha-synuclein.

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

T Cell Reactivity to Tau & Alpha-Synuclein in PD

Tau and alpha-synuclein are proteins that form aggregates which characterize various neurodegenerative disorders including Parkinson’s disease. This feed focuses on the reaction of T lymphocytes in response to tau and alpha-synuclein.

Synucleinopathies

Synucleinopathies are neurodegenerative diseases characterized by accumulation of alpha-synuclein protein aggregates in neurons and glial cells. Discover the latest research on synucleinopathies here.

Parkinson's Disease

Parkinson's Disease is a progressive neurodegenerative disorder characterized by loss of muscle control, including trembling of the limbs and impaired balance. Here is the latest research.

Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Parkinson's Disease: Alpha-Synuclein

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Tauopathies

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

© 2020 Meta ULC. All rights reserved

CSF α-synuclein, tau, and amyloid β in Parkinson's disease

Lancet Neurology

Jul 23, 2011

Min Shi, Jing Zhang

PMID: 21777821

DOI: 10.1016/s1474-4422(11)70130-2

Abstract

No abstract listed.

Mentioned in this Paper

MAPT protein, human
Peptide Fragments
Tau Proteins
Parkinson Disease
Alpha-Synuclein
Viral Markers
Amyloid beta-Peptides
Amyloid beta-protein (1-42)
1
18

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
/papers/csf--synuclein-tau-and-amyloid-in-parkinsons/21777821